Serge Belanger
Stock Analyst at Needham
(4.63)
# 201
Out of 5,182 analysts
405
Total ratings
56.69%
Success rate
24.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Buy | $42 → $32 | $14.23 | +124.88% | 21 | Mar 30, 2026 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $35 → $36 | $19.08 | +88.68% | 25 | Mar 25, 2026 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $54 → $56 | $32.28 | +73.48% | 29 | Mar 19, 2026 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $22 → $24 | $14.19 | +69.13% | 23 | Mar 18, 2026 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $58 → $80 | $55.41 | +44.38% | 15 | Mar 9, 2026 | |
| CRMD CorMedix | Maintains: Buy | $15 → $14 | $7.33 | +91.00% | 21 | Mar 5, 2026 | |
| LQDA Liquidia | Maintains: Buy | $52 → $54 | $37.46 | +44.15% | 36 | Mar 5, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $36 → $40 | $26.77 | +49.42% | 3 | Mar 4, 2026 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $4 → $5 | $1.91 | +161.78% | 21 | Mar 3, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $34 → $30 | $21.01 | +42.79% | 9 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $22.86 | +57.48% | 25 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $16.93 | +47.67% | 16 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $65.48 | +29.81% | 27 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.59 | +87.70% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $31.46 | +52.57% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $25.36 | +18.30% | 29 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.31 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.76 | +105.48% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.52 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.00 | +200.06% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.49 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.43 | - | 1 | Mar 31, 2022 |
Viridian Therapeutics
Mar 30, 2026
Maintains: Buy
Price Target: $42 → $32
Current: $14.23
Upside: +124.88%
KalVista Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $35 → $36
Current: $19.08
Upside: +88.68%
Collegium Pharmaceutical
Mar 19, 2026
Reiterates: Buy
Price Target: $54 → $56
Current: $32.28
Upside: +73.48%
Trevi Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $24
Current: $14.19
Upside: +69.13%
Xenon Pharmaceuticals
Mar 9, 2026
Maintains: Buy
Price Target: $58 → $80
Current: $55.41
Upside: +44.38%
CorMedix
Mar 5, 2026
Maintains: Buy
Price Target: $15 → $14
Current: $7.33
Upside: +91.00%
Liquidia
Mar 5, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $37.46
Upside: +44.15%
Oculis Holding AG
Mar 4, 2026
Maintains: Buy
Price Target: $36 → $40
Current: $26.77
Upside: +49.42%
Esperion Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $1.91
Upside: +161.78%
Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $21.01
Upside: +42.79%
Feb 26, 2026
Maintains: Buy
Price Target: $31 → $36
Current: $22.86
Upside: +57.48%
Feb 26, 2026
Reiterates: Buy
Price Target: $25
Current: $16.93
Upside: +47.67%
Feb 25, 2026
Maintains: Buy
Price Target: $84 → $85
Current: $65.48
Upside: +29.81%
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $9.59
Upside: +87.70%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $31.46
Upside: +52.57%
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $25.36
Upside: +18.30%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.31
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.76
Upside: +105.48%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.52
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.00
Upside: +200.06%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.49
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.43
Upside: -